Brilliant N.E.V. Corp. Reports No Revenue and $35,871 Net Loss for Fiscal Year Ending July 31, 2024

Brilliant N.E.V. Corp., formerly known as Clancy Corp., reported no operating revenue for the fiscal year ending July 31, 2024, maintaining its status as a shell company. The company recorded a net loss of $35,871, a significant reduction from the previous year's loss of $292,590, which included a $240,219 loss from discontinued operations related to its former subsidiaries in China. The decrease in net loss is attributed to the cessation of operations in China, which were transferred to Hongshan Yuanda Limited effective June 30, 2023. As of July 31, 2024, the company had cash and cash equivalents of $7,972, an increase from $1,302 in the prior year.

The company underwent a significant change in control on June 26, 2023, when approximately 52.056% of its outstanding common stock was transferred to Guangzhe Su. Following this change, Brilliant N.E.V. Corp. ceased operations of its China subsidiaries and subsequently amended its articles of incorporation to reflect its new name. The company’s strategy now focuses on preserving its reporting status while exploring potential business combinations or acquisitions, although it has not yet identified any new operating business.

Operationally, Brilliant N.E.V. Corp. reported no full-time employees as of July 31, 2024, relying instead on its officers and outside professionals for management functions. The company’s total liabilities increased to $49,244 from $6,703 in the previous year, primarily due to loans from related parties. The accumulated deficit rose to $308,710, reflecting ongoing financial challenges and the lack of revenue generation.

Looking ahead, the company faces substantial doubt regarding its ability to continue as a going concern, as highlighted by its independent auditors. Management plans to address these challenges through capital-raising efforts and potential strategic transactions, although there is no assurance of success. The company’s ability to meet its obligations will depend on securing additional funding and potentially diluting existing shareholders through the issuance of new equity securities. As of now, there is no active market for the company's common stock, which may further complicate its financial recovery efforts.